Phenytoin-induced pseudolymphoma: reevaluation using modern molecular biology techniques

Epilepsia
Y M JengI J Su

Abstract

Patients receiving phenytoin (PHT) may develop pseudolymphoma or, rare ly, malignant lymphoma. Previously, distinguishing the two diseases based solely on histopathology has been difficult. The recent introduction of molecular biologic techniques has provided a powerful tool to reassess this problem. A 17-year-old girl developed systemic lymphadenopathy after receiving PHT for 1 year for generalized tonic-clonic seizures (GTCS). Biopsy of a cervical lymph node showed diffuse proliferation of large lymphoid cells mimicking a large cell lymphoma. Immunophenotypic, immunoglobulin gene rearrangement, and cytogenic studies, however, showed polyclonal B-cell proliferation, consistent with PHT-induced pseudolymphoma. After PHT discontinuation, lymphadenopathy resolved in 1 month and no recurrence developed in the subsequent 10 months. Obtaining a history of drug use is crucial to recognizing this group of patients. Molecular biology and chromosome studies have become the definitive basis differentiating pseudolymphoma from malignant lymphoma in patients receiving chronic PHT therapy.

References

Oct 1, 1992·The British Journal of Dermatology·D W HarrisM H Rustin
Oct 30, 1971·Lancet·M Seabright
Jun 3, 1972·British Medical Journal·P J Grob, G E Herold
May 1, 1970·Archives of Neurology·J J Anthony

❮ Previous
Next ❯

Citations

May 8, 2000·Indian Journal of Pediatrics·R KhetarpalA K Bhalla
Dec 24, 2005·Clinical Nuclear Medicine·Girolamo Moschilla, Nat P Lenzo
Oct 27, 2004·Expert Opinion on Drug Safety·Noah Scheinfeld
Jul 27, 2012·Lancet Neurology·Piero Perucca, Frank G Gilliam
Nov 6, 2015·Indian Journal of Dermatology·Najeeba RiyazPappinissery K Nikhila
Jan 3, 2013·Seizure : the Journal of the British Epilepsy Association·Sujith OvallathSangeetha Nayanar
Jul 9, 2016·American Journal of Physical Medicine & Rehabilitation·Chang Ho Hwang
Aug 21, 2001·The Annals of Otology, Rhinology, and Laryngology·W M RalphH Kim
Oct 29, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M D AljurfA Tbakhi

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.